Calcium sensitizing in sepsis: Is levosimendan on the right path?

Critical Care Medicine

Volumn 36, Issue 6, 2008, Pages 1981-1982

  Ertmer, Christian ^a   Morelli, Andrea ^b   Westphal, Martin ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Levosimendan; Norepinephrine; Septic shock

Indexed keywords

CALCIUM; ENDOTHELIN 1; HYPERTENSIVE AGENT; LEVOSIMENDAN; NORADRENALIN; CARDIOTONIC AGENT; HYDRAZONE DERIVATIVE; OXYGEN; PHOSPHODIESTERASE INHIBITOR; PYRIDAZINE DERIVATIVE; SIMENDAN;

BLOOD FLOW; CELL PROTECTION; DRUG EFFECT; EDITORIAL; HEART MUSCLE CONTRACTILITY; HEART OUTPUT; HEMODYNAMICS; HUMAN; HYPOVOLEMIA; MICROCIRCULATION; MICROVASCULATURE; NONHUMAN; OXYGEN TRANSPORT; OXYGENATION; PERFUSION; PRIORITY JOURNAL; SENSITIZATION; SEPSIS; SEPTIC SHOCK; VASODILATATION; ANIMAL; BLOOD; COMPARATIVE STUDY; DISEASE MODEL; MOUTH MUCOSA; NOTE; RAT; VASCULAR ENDOTHELIUM; VASCULARIZATION;

ANIMALS; CALCIUM; CARDIOTONIC AGENTS; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; HEMODYNAMICS; HYDRAZONES; MICROCIRCULATION; MOUTH MUCOSA; NOREPINEPHRINE; OXYGEN; PHOSPHODIESTERASE INHIBITORS; PYRIDAZINES; RATS; REGIONAL BLOOD FLOW; SHOCK, SEPTIC;

EID: 45149116658     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e318176a807     Document Type: Editorial

References (12)

1. Westphal M, Morelli A, Van Aken H: Dear Levosimendan, the right ventricle will thank you! Crit Care Med 2007; 35:952-953
2. Dubin A, Murias G, Sottile JP, et al: Effects of levosimendan and dobutamine in experimental acute endotoxemia: A preliminary controlled study. Intensive Care Med 2007; 33: 485-494
3. Morelli A, De Castro S, Teboul JL, et al: Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression. Intensive Care Med 2005; 31: 638-644
4. Morelli A, Teboul JL, Maggiore SM, et al: Effects of levosimendan on right ventricular afterload in patients with acute respiratory distress syndrome: A pilot study. Crit Care Med 2006; 34:2287-2293
5. Gruhn N, Nielsen-Kudsk JE, Theilgaard S, et al: Coronary vasorelaxant effect of levosi-mendan, a new inodilator with calcium-sensitizing properties. J Cardiovasc Pharmacol 1998; 31:741-749
6. Parissis JT, Karavidas A, Bistola V, et al: Effects of levosimendan on flow-mediated va-sodilation and soluble adhesion molecules in patient with advanced chronic heart failure. Atherosclerosis 2007; 197:278-282
7. Schwarte LA, Picker O, Bornstein SR, et al: Levosimendan is superior to milrinone and dobutamine in selectively increasing micro-vascular gastric mucosal oxygenation in dogs. Crit Care Med 2005; 33:135-142
8. Fries M, Ince C, Rossant R, et al: Levosi-mendan but not norepinephrine improves microvascular oxygenation during experimental septic shock. Crit Care Med 2008; 36:1886-1891
9. Kevelaitis E, Peynet J, Mouas C, et al: Opening of potassium channels: The common car-dioprotective link between preconditioning and natural hibernation? Circulation 1999; 99:3079-3085
10. De Luca L, Colucci WS, Nieminem MS, et al: Evidence-based use of levosimendan in different clinical settings. Eur Heart J 2006; 27:1908-1920
11. Singer M: Mitochondrial function in sepsis: Acute phase versus multiple organ failure. Crit Care Med 2007; 35(Suppl 9):S441-S448
12. Buckley JF, Singer M, Clapp LH: Role of KATP channels in sepsis. Cardiovasc Res 2006; 72:220-230